中国糖尿病流行趋势深度解析：2050年患病率或突破30%大关

Core Viewpoint - The article highlights the alarming increase in diabetes prevalence in China, emphasizing the urgent need for effective prevention and control strategies to address this public health crisis [9][15][16]. Summary by Sections Diabetes Prevalence and Trends - As of 2023, the total number of diabetes patients in China has reached 233 million, with a prevalence rate of 15.88%, marking a 163% increase from 88.48 million patients in 2005 [9][15]. - The age-standardized prevalence rate (ASR) has risen from 7.53% in 2005 to 13.67% in 2023, with an annual growth rate of 3.36% [9][10]. - The years of life lost due to disability (YLDs) related to diabetes reached 32.49 million in 2023, reflecting a significant decline in overall health quality [9]. Regional Distribution and Characteristics - The eastern region has the highest number of diabetes patients at 78.47 million, followed by central and northern regions [11]. - The northern region has the highest ASR at 17.20%, with major cities like Beijing and Tianjin exceeding a 20% prevalence rate [12]. - The southwestern region shows the fastest growth in diabetes prevalence, increasing from 5.65% in 2005 to 11.77% in 2023, driven by dietary changes [12]. Future Projections and Challenges - Projections indicate that if current trends continue, the ASR could reach 16.15% by 2030, 21.52% by 2040, and potentially 29.10% by 2050, adding nearly 150 million new diabetes patients [13][15]. - The healthcare system will face unprecedented pressure due to the high costs associated with diabetes treatment and management [10][15]. Prevention and Control Strategies - The article advocates for a shift from treatment to early screening, lifestyle interventions, and strengthening primary healthcare [10][15]. - A differentiated regional strategy is necessary, focusing on complication management in high-prevalence areas and lifestyle interventions in rapidly growing regions [14][16]. - Implementing obesity intervention strategies could significantly reduce the projected diabetes prevalence by 2050, potentially keeping it below 15% [13][15].